{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:53:29Z","timestamp":1782878009864,"version":"3.54.5"},"reference-count":30,"publisher":"Tech Science Press","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2025]]},"DOI":"10.32604\/or.2025.064237","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T04:21:26Z","timestamp":1749097286000},"page":"2107-2121","source":"Crossref","is-referenced-by-count":3,"title":["Intrathecal Pemetrexed Administration and Myelosuppression in Patients with Leptomeningeal Metastases from Lung Adenocarcinoma: A Retrospective Study"],"prefix":"10.32604","volume":"33","author":[{"given":"Junxing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luping","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/ctrv.1999.0119","article-title":"Leptomeningeal carcinomatosis","volume":"25","author":"Grossman","year":"1999 Apr","journal-title":"Cancer Treat Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1474-4422(06)70443-4","article-title":"Neoplastic meningitis","volume":"5","author":"Gleissner","year":"2006 May","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2022.09.013","article-title":"Leptomeningeal metastases in non-small cell lung cancer: diagnosis and treatment","volume":"174","author":"Wang","year":"2022 Dec","journal-title":"Lung Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1158\/1078-0432.CCR-22-1585","article-title":"Leptomeningeal metastasis from non-small cell lung cancer and current landscape of treatments","volume":"29","author":"Ozcan","year":"2023 Jan 4","journal-title":"Clin Cancer Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"107475","DOI":"10.1016\/j.lungcan.2024.107475","article-title":"Effectiveness of high-dose third-generation EGFR-tyrosine kinase inhibitors in treating EGFR-mutated non-small cell lung cancer patients with leptomeningeal metastasis","volume":"188","author":"Wu","year":"2024 Feb","journal-title":"Lung Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.annonc.2021.02.012","article-title":"Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs","volume":"32","author":"Felip","year":"2021 May","journal-title":"Ann Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1200\/JCO.19.00457","article-title":"Osimertinib in patients with epidermal growth factor receptor mutation-positive non-small-cell lung cancer and leptomeningeal metastases: the BLOOM study","volume":"38","author":"Yang","year":"2020 Feb 20","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jtho.2019.01.007","article-title":"Clinical utility of cerebrospinal fluid cell-free DNA as liquid biopsy for leptomeningeal metastases in ALK-rearranged NSCLC","volume":"14","author":"Zheng","year":"2019 May","journal-title":"J Thorac Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.jtho.2016.06.029","article-title":"Leptomeningeal metastases in patients with NSCLC with EGFR mutations","volume":"11","author":"Li","year":"2016","journal-title":"J Thorac Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3892\/ol.2016.4783","article-title":"Intrathecal chemotherapy as a treatment for leptomeningeal metastasis of non-small cell lung cancer: a pooled analysis","volume":"12","author":"Wu","year":"2016 Aug","journal-title":"Oncol Lett"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3389\/fonc.2019.00838","article-title":"A pilot phase 1 study of intrathecal pemetrexed for refractory leptomeningeal metastases from non-small-cell lung cancer","volume":"9","author":"Pan","year":"2019 Aug 30","journal-title":"Front Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"175883592093795","DOI":"10.1177\/1758835920937953","article-title":"Intrathecal pemetrexed combined with involved-field radiotherapy as a first-line intra-CSF therapy for leptomeningeal metastases from solid tumors: a phase I\/II study","volume":"12","author":"Pan","year":"2020 Jan","journal-title":"Ther Adv Med Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1016\/j.cllc.2022.11.011","article-title":"Safety, pharmacokinetic and clinical activity of intrathecal chemotherapy with pemetrexed via the ommaya reservoir for leptomeningeal metastases from lung adenocarcinoma: a prospective phase I study","volume":"24","author":"Li","year":"2023 Mar","journal-title":"Clin Lung Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.jtho.2021.04.018","article-title":"Efficacy and safety of intrathecal pemetrexed combined with dexamethasone for treating tyrosine kinase inhibitor-failed leptomeningeal metastases from EGFR-mutant NSCLC\u2014a prospective, open-label, single-arm phase 1\/2 clinical trial (unique identifier: ChiCTR1800016615)","volume":"16","author":"Fan","year":"2021 Aug","journal-title":"J Thorac Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"102384","DOI":"10.1016\/j.esmoop.2024.102384","article-title":"Efficacy and safety of intrathecal pemetrexed for TKI-failed leptomeningeal metastases from EGFR+ NSCLC: an expanded, single-arm, phase II clinical trial","volume":"9","author":"Fan","year":"2024 Apr","journal-title":"ESMO Open"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/s12885-023-10806-5","article-title":"Intrathecal chemotherapy combined with systemic therapy in patients with refractory leptomeningeal metastasis of non-small cell lung cancer: a retrospective study","volume":"23","author":"Zhou","year":"2023 Apr 11","journal-title":"BMC Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3390\/pharmaceutics14050914","article-title":"A pharmacometric model to predict chemotherapy-induced myelosuppression and associated risk factors in non-small cell lung cancer","volume":"14","author":"Park","year":"2022 Apr 22","journal-title":"Pharmaceutics"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.3390\/cancers16142597","article-title":"Chemotoxicity and associated risk factors in colorectal cancer: a systematic review and meta-analysis","volume":"16","author":"Han","year":"2024 Jul 20","journal-title":"Cancers"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.critrevonc.2013.12.006","article-title":"Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: a systematic review","volume":"90","author":"Lyman","year":"2014 Jun","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ygyno.2012.03.015","article-title":"Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer","volume":"125","author":"Laskey","year":"2012 Jun","journal-title":"Gynecol Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"101624","DOI":"10.1016\/j.esmoop.2023.101624","article-title":"Leptomeningeal metastasis from solid tumours: EANO-ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"8","author":"Le Rhun","year":"2023 Oct","journal-title":"ESMO Open"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cncr.11882","article-title":"Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management","volume":"100","author":"Crawford","year":"2004 Jan 15","journal-title":"Cancer"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/cncr.21847","article-title":"Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients","volume":"106","author":"Kuderer","year":"2006 May 15","journal-title":"Cancer"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1002\/cncr.25332","article-title":"Risk of mortality in patients with cancer who experience febrile neutropenia","volume":"116","author":"Lyman","year":"2010 Dec","journal-title":"Cancer"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e2073","DOI":"10.1212\/WNL.0000000000200254","article-title":"Sex-dependent analysis of temozolomide-induced myelosuppression and effects on survival in a large real-life cohort of patients with glioma","volume":"98","author":"Zeiner","year":"2022 May 17","journal-title":"Neurology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11060-023-04483-4","article-title":"Effects of intrathecal pemetrexed on the survival of patients with leptomeningeal metastasis from lung adenocarcinoma: a propensity score matching analysis","volume":"165","author":"Hong","year":"2023 Nov","journal-title":"J Neuro-Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"153303382210784","DOI":"10.1177\/15330338221078429","article-title":"A retrospective study of intrathecal pemetrexed combined with systemic therapy for leptomeningeal metastasis of lung cancer","volume":"21","author":"Geng","year":"2022 Jan","journal-title":"Technol Cancer Res Treat"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-200544010-00001","article-title":"Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis","volume":"44","author":"Fleischhack","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1148\/radiology.216.3.r00au37672","volume":"216","author":"Courchesne","year":"2000 Sep","journal-title":"Radiology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12967-022-03331-9","article-title":"Potential benefit of osimertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancer","volume":"20","author":"Yi","year":"2022 Dec","journal-title":"J Transl Med"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.techscience.cn\/files\/or\/2025\/TSP_OR-33-8\/OncolRes-33-08-64237\/OncolRes-33-64237.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T01:53:54Z","timestamp":1763344434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v33n8\/63052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2025.064237","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}